In the SELECT study, however, <10% of men were smokers, most had an early-stage cancer detected by prostate-specific antigen (PSA) blood tests, and the study was stopped earlier than expected as it did not appear to give no cancer or prostate cancer prevention results [56,60] (Table 1). This evidence concerns the gene KLK3 and prostate carcinoma.